Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share of Common Stock

v3.24.1.1.u2
Net Loss per Share of Common Stock
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Net Loss per Share of Common Stock

Note 4 – Net Loss per Share of Common Stock

 

Net Loss Per Share

 

Basic net loss per share is computed by dividing our net loss available to common shareholders by the weighted average number of shares of common stock outstanding (which excludes unvested RSAs and includes vested RSUs) during the period. Diluted loss per share is computed by dividing our net loss available to common shareholders by the diluted weighted average number of shares of common stock (which includes the potentially dilutive effect of stock options, unvested RSAs, unvested RSUs and warrants) during the period. Since we experienced a net loss for both periods presented, basic and diluted net loss per share are the same. As such, diluted loss per share for the three months ended March 31, 2024 and 2023 excludes the impact of potentially dilutive common shares since those shares would have an anti-dilutive effect on net loss per share.

 

The computation of net loss per share for the three months ended March 31, 2024 and 2023 was as follows:

 

    2024     2023  
   

Three months ended

March 31,

 
    2024     2023  
Basic and diluted net loss per share:                
Net loss available to common stockholders   $ (2,726,381 )   $ (4,022,073 )
Weighted average number of common shares-basic and diluted     2,466,523       1,138,573  
                 
Basic and diluted net loss per share   $ (1.11 )   $ (3.53 )

 

    2024     2023  
Weighted-average number of common shares outstanding – basic and diluted     2,331,867       1,010,410  
Weighted-average number of vested RSUs– basic and diluted     134,657       128,164  
Weighted-average number of common shares-basic and diluted     2,466,523       1,138,573  

 

Our diluted net loss per share for the three months ended March 31, 2024 and 2023 excluded 1,866,753 and 236,496 of potentially dilutive common shares, respectively, related to outstanding stock options, warrants and unvested restricted stock since those shares would have had an anti-dilutive effect on net loss per share during the periods then ended.